Deletion of Ca
Introduction
The calcium/calmodulin dependent protein kinase II (CaMKII) is a dodecameric enzyme consisting of subunits encoded by four different genes known as CaMKIIα, β, γ, and δ. The predominant cardiac isoform is CaMKIIδ and it is alternatively spliced in the heart to generate CaMKIIδ B and CaMKIIδ C as well as other minor subtypes [1] [2] [3] [4] [5] . We have generated global and cardiac specific knockouts of CaMKIIδ and demonstrated that deletion of this protein ameliorates heart failure development in response to pressure overload, Gα q expression, and isoproterenol infusion [6] [7] [8] . We further reported that deletion of CaMKIIδ diminishes infarct development in response to in vivo ischemia/reperfusion [9] . Other studies using CaMKII inhibitory peptides or knock-ins of activation-deficient CaMKII have similarly concluded that CaMKII activation by a range of cardiac insults, including myocardial infarction, is deleterious [10] [11] [12] [13] . In all of the aforementioned studies both the CaMKIIδ B and CaMKIIδ C subtypes of CaMKIIδ were genetically deleted or inhibited. Accordingly it is not yet known which subtype is responsible for the protective effect of ablating CaMKIIδ activity in the heart.
The studies reported here use mice in which CaMKIIδ deletion has been restored by crossing CaMKIIδKO mice with transgenic lines expressing either the CaMKIIδ B (δ B TG/δKO) or CaMKIIδ C (δ C TG/δKO) subtype [14] . This approach allowed us to examine the unique roles of CaMKIIδ B and CaMKIIδ C in cardiomyocyte survival and infarct formation in response to I/R. We demonstrate that CaMKIIδ C expression reverses and exacerbates the diminished I/R damage observed in CaMKIIδKO mouse hearts whereas CaMKIIδ B expression further attenuates I/R damage. The difference in infarct development observed in δ B TG/δKO and δ C TG/δKO mice is associated with greater I/R-induced inhibitor of kappa B kinase (IKK) and NF-κB activation in δ C TG/δKO mice. CaMKIIδ C -mediated NF-κB activation is recapitulated in NRVMs exposed to oxidative stress, and selective activation of CaMKIIδ C in a cytosol/membrane fraction is observed in NRVMs exposed to oxidative stress and in hearts exposed to I/R. TNF-α expression is also selectively increased in hearts from δ C TG/δKO mice following I/R. Blocking either IKK activation or TNF-α signaling diminished infarct development in δ C TG/δKO as well as in WT mice. These data suggest that selective activation of the CaMKIIδ C subtype in cardiomyocytes regulates cardiac-autonomous pro-inflammatory signaling events that contribute to ischemia/reperfusion injury.
Methods

Transgenic animals
Transgenic Black Swiss mice in which the predominant cardiac subtypes of CaMK, CaMKIIδ B and CaMKIIδ C , are over expressed were generated in our laboratory and characterized as described [15, 16] . Conventional CaMKIIδKO mice were generated and characterized as previously described [6] . CaMKIIδ B and CaMKIIδ C transgenic mice were crossed with conventional CaMKIIδKO mice to generate mice that express only CaMKIIδ B or CaMKIIδ C . We refer to these animals as CaMKIIδ B TG/δKO and CaMKIIδ C TG/δKO. All mice used in the present study were male at 8 weeks of age, unless otherwise noted. Animal studies were performed in accordance with the NIH Guide for the Care and Use of Laboratory Animals and approved by the Institutional Animal Care and Use Committees of University of California at San Diego.
CaMKII activity assay
CaMKII activity was measured in ventricular homogenate using Syntide-2, a synthetic CaMKII-specific substrate peptide. Hearts were isolated and ventricles homogenized in lysis buffer (50 mmol/L HEPES, 10% ethylene glycol, 2 mg/mL BSA, 5 mmol/L EDTA, pH 7.5), and assayed immediately without freezing. The assay buffer contained 50 mmol/L HEPES, 10 mmol/L magnesium acetate, 1 mg/mL BSA, 20 μmol/L Syntide-2, 1 mmol/L DTT, 400 nM [γ-32 P]ATP, pH 7.5 and either 1 mmol/L EGTA (for autonomous activity) or 500 μmol/L CaCl 2 , plus 1 μmol/L calmodulin (for maximal activity). The reaction was carried out at 30°C for 10 min and blotted onto Whatman P81 phosphocellulose paper.
Heart tissue fractionation procedure
Mice were killed by cervical dislocation, and hearts were quickly removed and placed in ice-cold PBS. Following cannulation, hearts were perfused with PBS to remove blood, frozen in liquid N 2 , and pulverized. Tissue was then homogenized in isolation buffer (70 mmol/L sucrose, 190 mmol/L mannitol, 20 mmol/L HEPES, 0.2 mmol/L EDTA) that was supplemented with various inhibitors: sodium vanadate, leupeptin, aprotinin, p-nitrophenyl phosphate, and phenylmethylsulfonyl fluoride. Homogenate was centrifuged at 600g for 10 m at 4°C, and the supernatant transferred to another tube. The supernatant was centrifuged at 5000g for 15 m at 4°C to yield a cytosol/membrane fraction. The pellet from the initial 600 g centrifugation was resuspended in nuclear lysis buffer (20 mmol/L NaCl, 1.5 mmol/L MgCl 2 , 20 mmol/L HEPES, 200 nmol EDTA, 25% glycerol) and centrifuged at 600g for 10 m at 4°C to yield a nuclear fraction.
Neonatal rat ventricular myocyte (NRVM) isolation and adenoviral infection
Neonatal rat ventricular myocytes (NRVMs) were isolated from 1 to 2-day-old Sprague-Dawley rat pups, digested with collagenase, plated at density of 3.5 × 10 4 /cm 2 and maintained overnight in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal calf serum and antibiotics (100 units/mL penicillin and 100 μg/mL streptomycin), Prior to adenoviral Infection, isolated NRVMs were transferred to serum-free medium and infected with CaMKII δ B or δ C adenovirus at 10, 30, 50, 100, 300 multiplicity of infection (MOI) for 3 h. Cells were washed and maintained in serum-free medium for an additional 21 h prior to treatment with H 2 O 2 or vehicle. To assess changes in nuclear and cytosolic/membrane fractions, NRVMs were fractionated according to a previously reported protocol [17] . Purity was determined using the cytosolic marker Rho GDP dissociation inhibitor (RhoGDI) and the nuclear marker Lamin A/C.
Transthoracic echocardiography
Echocardiography was performed using the VisualSonics VeVo 770 Imaging System (VisualSonics, Toronto, Canada) equipped with highfrequency 30 MHz probe, as described [18] . Body temperatures were maintained between narrow ranges (37.0 ± 1.0°C) to avoid confounding effects of hypothermia.
Isolated perfused (ex vivo) I/R
Mice were killed by cervical dislocation, and hearts were quickly removed and placed in ice-cold Ca 2+ -free Krebs-Henseleit buffer. Aortas were cannulated and hearts perfused by gravity flow on a Langendorff perfusion system (Radnoti LLC) at 37°C and a constant pressure of 80 mm Hg with a modified Krebs-Henseleit buffer solution containing (in mmol/L); 2.0 CaCl 2 , 130 NaCl, 5.4 KCl, 11 dextrose, 2 pyruvate, 0.5 MgCl 2 , 0.5 NaH 2 PO 4 , and 25 NaHCO 3 and aerated with 95% oxygen and 5% carbon dioxide, pH 7.4. To measure infarct size, hearts were subjected to 25-minute global ischemia and 1-hour reperfusion; the ventricles were then frozen and cut transversely into 5 slices of equal thickness. The slices were then incubated in 1% TTC/PBS and fixed in 10% formalin-PBS for 24 h. Fixed slices were then scanned, and ImageJ was used to measure and calculate the size of the infarct area and the total area. For experiments utilizing BMS-345541 (Sigma-Aldrich) the drug was dissolved in Krebs-Henseleit buffer solution at a concentration of 5 μmol/L and was present throughout the I/R protocol. For those using etanercept, the drug was present for the entire I/R procedure at a concentration of 5 μg/mL. To assess cardiac function, a water-filled balloon connected to a pressure transducer (Gould Stathem P23 ID) was inserted into the left ventricle through the left atrium to monitor left ventricular developed pressure (LVDP); data collected using Powerlab, were processed with AD Instruments Chart 4 software (v4.12). Hearts were submersed in warm KHB (37°C) throughout the perfusion. Functional recovery was expressed as a percentage of pre-ischemic LVDP.
Immunoblotting
Ventricular tissue was homogenized in RIPA buffer (10 mmol/L TrisCl (pH 8.0), 1 mmol/L EDTA, 0.5 EGTA, 1% Triton X-100, 0.1% sodium deoxycholate, 0.1% SDS, 140 mmol/L NaCl) that was supplemented with various inhibitors: sodium vanadate, leupeptin, aprotinin, p-nitrophenyl phosphate, and phenylmethylsulfonyl fluoride. Western blot analysis was performed according to protocols described previously [9] . The antibodies for immunoblotting were as follows: CaMKIIδ (D.M. Bers, UC Davis); GAPDH (CST); phospho-IKKα/β at its autophosphorylation site (Ser176/180) (CST); phospho-CaMKII at its autophosphorylation site (Thr286) (Thermo); NF-κB p65 (CST); α-actinin (CST); RhoGDI (CST); Lamin A/C (CST); IκBα (CST)
RT-PCR
RNA extraction for real time analysis was performed using the solidphase RNeasy purification kit from Qiagen (Venlo, Netherlands). First strand cDNA synthesis for Real time PCR was performed using the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Grand Island, NY). Gene expression was determined using Taqman® Universal PCR master mix, Cy5-labeled Taqman® probe for TNF-α and IL-6 and FAM-labeled Taqman® probe for GAPDH (Applied Biosystems).
Statistical analysis
Data are presented as mean ± SEM as indicated and were analyzed by 2-tailed Student t-test between 2 groups or by ANOVA when 3 or more groups were compared. P values b0.05 were considered statistically significant.
Results
To examine the independent roles of the CaMKIIδ B and δ C subtypes in the heart we restored either δ B or δ C expression in a CaMKIIδ-null (KO) background. The resulting animals express only δ B (δ B TG/δKO) or only δ C (δ C TG/δKO). Survival of WT, KO, δ B TG/δKO, and δ C TG/δKO mice was assessed. Deletion of CaMKIIδ produced no overt phenotypic changes and did not affect survival relative to WT mice as shown previously [6] . δ B TG/δKO animals also survived normally for at least 6 months. In contrast, the δ C TG/δKO animals, like the previously studied δ C TG [16] , exhibited premature death with b20% survival by 21 weeks (Fig. 1A) . Expression of the CaMKII δ B and δ C subtypes also had markedly different effects on in vivo cardiac function. Echocardiography on 6-8 week old mice revealed that fractional shortening (FS) was decreased by 63% in δ C TG/δKO mice compared to WT mice (Fig. 1B ) while δ B TG/δKO animals did not display cardiac dysfunction.
We previously demonstrated that CaMKIIδ deletion attenuates I/R injury in response to in vivo left anterior descending coronary artery occlusion and subsequent reperfusion [9] . To examine the cardiacintrinsic role of CaMKIIδ in I/R we performed ex vivo I/R experiments on isolated perfused hearts from 8-week-old mice. Infarct formation following 25 min ischemia and 1 h reperfusion was determined by TTC staining of heart sections. In WT animals, ex vivo I/R induced infarcts comprising 36.2 ± 2.5% of the cross-sectional area. Infarcts were significantly smaller, only 24.1 ± 1.4%, in CaMKIIδKO mouse hearts ( Fig. 2A,  B) . Thus regulation of infarct development by CaMKII is evident not only in vivo but also in an ex vivo I/R model.
Hearts from δ B TG/δKO mice were then examined and found to be protected against ex vivo I/R damage, with infarcts measuring 12.2 ± 1.9% of cross-sectional area. Conversely, in δ C TG/δKO mouse hearts, the protective effect of CaMKIIδ gene deletion was lost with infarcts measuring 45.2 ± 1.8% of the cross-sectional area, significantly larger than those of WT, KO, and δ B TG/δKO ( Fig. 2A, B) . Assessment of left ventricular developed pressure (LVDP) recovery during reperfusion confirmed that expression of CaMKIIδ C in CaMKIIδKO mice exacerbates I/R damage while expression of CaMKIIδ B does not (Supplemental Fig. 1) .
CaMKII is known to be activated during ex vivo I/R [19, 20] , but previous experiments have not assessed subtype-specific CaMKII activation. Although we previously demonstrated that δ B and δ C can be equivalently activated by several pharmacological interventions [14] , we wondered if I/R might lead to differential activation of the two subtypes. To assess I/R-induced activation of CaMKII we analyzed phosphorylation of CaMKII at its autophosphorylation site threonine-286. The increases in CaMKII autophosphorylation observed in whole cell lysates from hearts of δ B TG/δKO and δ C TG/δKO mice subjected to I/R were equivalent (Fig. 3A) .
Many substrates of CaMKIIδ C (e.g. phospholamban, RyR2, and histone deacetylase 4) localize to the cytosol or the cytosolic face of the cardiac sarcoplasmic reticular (SR) membrane. Thus we carried out further studies using a subcellular fraction enriched for cytosolic and membrane proteins. Strikingly in this fraction we observed differential activation of the δ B and δ C subtypes in response to I/R. Indeed whereas no increases in CaMKII autophosphorylation were observed in cytosolic/membrane fractions from δ B TG/δKO mouse hearts, there was a N3-fold increase in autophosphorylated CaMKII in cytosolic/membrane-enriched fractions from δ C TG/δKO hearts (Fig. 3B) .
Our earlier studies examining in vivo I/R damage linked the deleterious effects of CaMKII to activation of IKK and subsequent NF-κB nuclear accumulation [9] . To determine which CaMKIIδ subtype was responsible, and also to determine if CaMKIIδ-mediated NF-κB activation can occur in the absence of systemic factors (e.g. leukocyte infiltration), we examined regulation of IKK and NF-κB by I/R in the ex vivo heart. The phosphorylation of IKK was found to be elevated during ex vivo reperfusion in δ C TG/δKO mice but not in δ B TG/δKO mice (Fig. 4A) . Furthermore I/R-mediated activation of IKK in δ C TG/δKO mice was associated with an increased nuclear localization of the p65 subunit of NF-κB, which was not observed in δ B TG/δKO animals (Fig. 4B) .
Nuclear p65 translocation would be expected to result in transcriptional activation of NF-κB target genes. Thus as further evidence that differences in NF-κB activation in δ C TG/δKO and δ B TG/δKO are functionally significant, we measured mRNA levels of genes regulated by NF-κB. Ischemia/reperfusion increased interleukin 6 (IL-6) mRNA in hearts from δ C TG/δKO mice to a greater extent than in those from δ B TG/δKO mice (Fig. 5A) . Even more striking was the robust increase in TNF-α expression in δ C TG/δKO mice and the absence of upregulation of this gene in δ B TG/δKO animals (Fig. 5B) . To confirm that oxidative stress can lead to selective activation of CaMKIIδ C and of NF-κB in a cardiomyocyte-autonomous fashion, we infected NRVMs with adenovirus expressing CaMKIIδ B or CaMKIIδ C. Cells were infected with a range of MOIs of CaMKIIδ B or δ C virus and subsequently treated with 50 μM H 2 O 2 for 30 min to elicit CaMKII and NF-κB activation. In NRVM whole cell lysates we observed equivalent activation of CaMKIIδ B and CaMKIIδ C in response to H 2 O 2 at all MOIs (Fig.  6A, top panel) , as quantitated using an MOI of 50 (Fig. 6A lower  panel) . In NRVM lysates that were fractionated to enrich for cytosolic and membrane proteins, however, there was significantly greater activation of CaMKIIδ C following H 2 O 2 treatment (Fig. 6B) . We further determined that expression of CaMKIIδ C , but not CaMKIIδ B , enhanced H 2 O 2 -mediated I kappa B alpha (IκBα) degradation (Fig. 6C ) and nuclear p65 accumulation (Fig. 6D) . These data, like those obtained in the isolated perfused heart (Figs. 3 and 4) suggest that oxidative stressinduced CaMKIIδ C activation in the cytosolic/membrane compartment is associated with activation of NF-κB.
To demonstrate that the deleterious effects of CaMKIIδ C activation seen in the isolated perfused heart were mediated by IKK/NF-κB signaling we blocked IKK activation with the pharmacological inhibitor BMS-345541 (BMS) [21] . Since this drug had not, to our knowledge, been used in the ex vivo perfused heart we evaluated its efficacy and determined a dose (5 μmol/L) that sequestered p65 in the cytosol/membrane fraction (Supplemental Fig. 2 ). Hearts from δ B TG/δKO, δ C TG/δKO, WT, and KO mice were then exposed to 5 μmol/L BMS or vehicle prior to and throughout the I/R protocol. Infarct size was significantly reduced by BMS administration in WT and δ C TG/δKO mice, while the already diminished infarct formation that was observed in δ B TG/δKO animals was not affected (Fig. 7) . CaMKIIδKO animals showed a modest but significant further reduction in infarct size.
In light of the selective increase in TNF-α mRNA in δ C TG/δKO mice, and evidence that active TNF-α can be produced in and secreted from the isolated perfused heart [22] , we asked whether TNF-α mediated the deleterious effects of CaMKIIδ C . For these studies we used etanercept, which blocks the effects of TNF-α by preventing its interaction with TNF-α receptors [23, 24] . Etanercept was perfused at 5 μg/mL prior to and throughout the I/R protocol. The results were similar to those obtained with IKK/NF-κB inhibition i.e. infarct size was significantly reduced in WT and δ C TG/δKO mice and was not reduced further in δ B TG/δKO animals. CaMKIIδKO animals showed modest but significant further reductions in infarct size in the presence of etanercept (Fig. 8) . These findings reveal a surprisingly important role for autocrine and/or paracrine TNF-α signaling in the ex vivo isolated perfused heart during I/R, demonstrate that this process is regulated by CaMKIIδ C , and establish an essential cardiac-intrinsic role for NF-κB in I/R injury (Fig. 9) . Fig. 3 . CaMKIIδ C is selectively activated in a subcellular fraction containing cellular membranes and cytosol. A, Lysates from the hearts of δ B TG/δKO and δ C TG/δKO mice were subjected to western blot analysis using an antibody specific for autophosphorylated CaMKII. Data are mean ± SEM values from 4 to 6 mice. B, Subcellular fractionation of hearts from δ B TG/δKO and δ C TG/δKO mice was carried out as described in methods yielding a fraction that includes cytosol and cellular membranes. Data are mean ± SEM values from 4 to 6 mice. *P b 0.05 vs sham.
Discussion
Our laboratory previously demonstrated that mice in which CaMKIIδ was selectively deleted from cardiomyocytes exhibited diminished infarct formation in response to in vivo I/R [9] . These experiments provided evidence that CaMKIIδ activation in cardiomyocytes mediates the deleterious effects of I/R injury but did not address the question of which subtype(s) of CaMKIIδ were responsible for cardiomyocyte death in response to I/R. Here we characterize and utilize mice in which the CaMKIIδ B or CaMKIIδ C isoforms are expressed in the CaMKIIδ KO animals to independently determine the role of each of these isoforms in cardiomyocyte CaMKII signaling. In addition we analyzed I/R damage in the ex vivo isolated perfused heart where the role of systemic inflammatory factors is eliminated. Our studies demonstrate that signals that are rapidly and locally generated regulate infarct development in the ex vivo heart and are significantly attenuated in the absence of CaMKIIδ. We further show that CaMKIIδ C re-expression in cardiomyocytes reverses the attenuation of infarct formation seen in CaMKIIδKO mice. In contrast CaMKIIδ B re-expression further limits infarct development compared to that observed in KO mice.
While total CaMKIIδ expression and maximal activity are somewhat higher in δ C TG/δKO mice (Supplemental Fig. 3 B) the amount of activated (Ca 2+ -autonomous) CaMKII is similar in δ C TG/δKO and δ B TG/δKO animals (Supplemental Fig. 3 A) . Thus it is unlikely that differential baseline levels of active CaMKIIδ explain the response of δ C TG/δKO versus δ B TG/δKO animals to I/R. There may, however, be a greater propensity for activation of inflammatory responses when CaMKIIδ C is activated thus we determined whether I/R could lead to selective increases in NF-κB activation in δ C TG/δKO mice. NF-κB has been implicated in in vivo I/R damage and myocardial infarction and our earlier studies demonstrated that CaMKIIδ activates NF-κB during in vivo I/R [9, 25, 26] . We previously assumed that in vivo I/R triggered systemic responses such as infiltration of non-cardiac inflammatory cells into the heart during the 24-48 h of reperfusion, and that this was a significant contributor to infarct development. Here, however, we demonstrate that CaMKIIδ C and subsequent NF-κB-mediated responses occur in the isolated perfused heart implicating cardiac-intrinsic signaling in the effects of CaMKIIδ C on infarct formation. It is possible that the deleterious effect of CaMKIIδ C is initiated by induction of cardiomyocyte cell death and release of factors from necrotic cells that induce inflammatory signaling [27, 28] . Our previous work showed, however, that cyclosporine-A (CsA) treatment did not block NF-κB activation in response to in vivo I/R, indicating that this response Fig. 4 . The NF-κB pathway is activated in CaMKIIδ C TG/δKO mice following reperfusion. A. Activation of IKK was assessed in δ B TG/δKO and δ C TG/δKO mice using an antibody specific for auto-phosphorylated IKKα/β. B, NF-κB p65 accumulation was assessed in nuclear extracts made from hearts of δ B TG/δKO and δ C TG/δKO mice subjected to ex vivo I/R. Data are mean ± SEM values from 6 mice. P b 0.05 vs sham. was independent of necrosis [9] and we confirmed this in the current ex vivo study (Supplemental Fig. 4 ). Accordingly we suggest that there is a direct effect of CaMKII on NF-κB activation. This conclusion is further supported by our current data showing that acute activation of CaMKIIδ C with H 2 O 2 elicits NF-κB activation in NRVMs and by our previous demonstration that adenoviral expression of activated CaMKIIδ C in NRVMs induces IKK activation [9] . Strikingly, we show here that NF-κB activation in response to I/R is enhanced by cardiac expression of CaMKIIδ C but not CaMKIIδ B . This is consistent with the finding that phosphorylation of the upstream kinase IKK is increased by I/R in δ C TG/δKO but not in δ B TG/δKO animals. Furthermore, we demonstrate that I/R increases activation of CaMKIIδ C but not of CaMKIIδ B in the cytosol/membrane, where IKK is localized. We previously reported that despite its nuclear localization sequence [29] CaMKIIδ B is not strictly confined to the nucleus [14] but is in fact present in the cytosol/membrane compartment (Fig. 3B) . It remains unclear why there is selective activation of CaMKIIδ C and not CaMKIIδ B in this location. Nevertheless our observations in NRVMs confirm that there is differential activation of equivalently expressed levels of CaMKIIδ B and δ C by oxidative stress and further indicate an association between cytosolic CaMKIIδ C autophosphorylation and subsequent IκBα degradation and nuclear accumulation of p65. Notably another recent report confirmed the ability of CaMKIIδ subtypes to undergo differential posttranslational modification during reperfusion [30] .
Previous studies using pharmacological inhibitors to demonstrate involvement of CaMKIIδ in ex vivo I/R damage linked the effects of CaMKII to phosphorylation of PLN and RyR2 and subsequent Ca 2+ dysregulation [31] , supporting the hypothesis that rapid phosphorylation of CaMKII targets was a driver of myocardial injury. Indeed, we originally considered it unlikely that transcriptional regulation by CaMKIIδ C -mediated activation of NF-κB could play a significant role in determining cell viability over the course of only one hour of reperfusion. Surprisingly, however, we found that inhibition of either IKK or TNF-α had a profound effect on infarct formation not only in δ C TG/ δKO but also in WT mouse hearts subjected to 25 min ex vivo ischemia and 60 min reperfusion.
Recent studies have shown that receptor-interacting protein kinase 3 (RIP3) plays a role in TNF-α-mediated cell death through formation of the necrosome [32] . RIP3 phosphorylates and activates CaMKII during I/R [33] accordingly TNF-α could participate in a deleterious positive feedback loop leading to sustained CaMKIIδ C and NF-κB activation. The experiments presented in this study clearly indicate that TNF-α signaling and myocardial NF-κB activation are mechanisms by which CaMKIIδ C elicits infarct formation in the isolated perfused heart. This signaling would likely be further enhanced and sustained by Ca 2+ dysregulation resulting from CaMKII-mediated phosphorylation of SR substrates and increases in reactive oxygen species (ROS) during I/R [19, 34, 35] . Paradoxically, some reports indicate that NF-κB may be protective in I/R injury [36, 37] while others demonstrate a deleterious role for NF-κB activation [25, 38] . Importantly, these studies differ in how I/R is elicited and how NF-κB is inhibited, thus resolution of these conflicting conclusions remains elusive. In the current study we have demonstrated that CaMKIIδ C expressed in cardiomyocytes mediates NF-κB activation, TNF-α induction and infarct development during I/R and that these events occur rapidly and in the absence of systemic inflammatory factors. Our data contribute to the understanding of the dichotomous effects of NF-κB by clearly demonstrating an adverse cardiomyocyteautonomous role of NF-κB activation in I/R injury.
While we demonstrate that cardiac TNF-α expression during I/R is mediated by CaMKIIδ C activation in cardiomyocytes, we do not know the extent to which TNF-α is formed in and secreted from these cells. Cardiac-resident macrophages and other non-myocytes are potential sources of TNF-α and could thus act in an autocrine or paracrine fashion to affect cardiomyocyte survival. The extent to which CaMKIIδ C activation in myocytes sends signals to other cells is not clear, but our studies demonstrate that the cardiomyocyte initiates signals though CaMKIIδ that lead to upregulation of TNF-α. TNF-α inhibitors such as etanercept have been used to inhibit TNF-α signaling in patients with various autoimmune disorders [39] . Effects of TNF-α inhibitors on cardiovascular disease outcomes have also been evaluated with uncertain results that could in part be due to systemic responses to sustained antibody administration [28] . Such detrimental effects would not be expected to occur during short-term treatment thus use of TNF-α inhibitors could be of value if employed at the onset of reperfusion following primary percutaneous intervention for myocardial infarction.
In summary, we demonstrate that the δ C isoform of CaMKII contributes significantly to myocardial damage following ex vivo I/R. Signaling occurs through NF-κB and TNF-α and acute inhibition of the generation or function of these molecules has a very robust protective effect in WT animals and in those expressing CaMKIIδ C . Importantly, we show that these events occur during a much shorter timeframe than would have been predicted by previous studies of CaMKIIδ and NF-κB signaling in in vivo I/R, and that these events occur in the absence of systemic factors such as infiltration of cells originating outside of the heart. CaMKII inhibition is predicted to be of therapeutic benefit in a number of contexts. Our results suggest that selective CaMKIIδ C inhibition would confer the most benefit over blockade of all cardiac CaMKII isoforms although specific means of locally inhibiting the δ C isoform do not yet exist. An alternative approach would be to acutely block events that occur downstream of CaMKIIδ C activation during I/R such as IKK/NF-κB activation or TNF-α signaling.
Supplementary data to this article can be found online at http://dx. doi.org/10.1016/j.yjmcc.2017.01.002.
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